nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine—CYP2C8—Mometasone—systemic scleroderma	0.0792	0.112	CbGbCtD
Quinidine—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.0745	0.106	CbGbCtD
Quinidine—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.0655	0.0929	CbGbCtD
Quinidine—SLCO1A2—Prednisone—systemic scleroderma	0.0632	0.0896	CbGbCtD
Quinidine—CYP1A2—Pentoxifylline—systemic scleroderma	0.0414	0.0588	CbGbCtD
Quinidine—CYP1A2—Leflunomide—systemic scleroderma	0.0395	0.0561	CbGbCtD
Quinidine—ABCB1—Lisinopril—systemic scleroderma	0.0362	0.0514	CbGbCtD
Quinidine—CYP2C9—Leflunomide—systemic scleroderma	0.0356	0.0505	CbGbCtD
Quinidine—SLCO1A2—Methotrexate—systemic scleroderma	0.0317	0.045	CbGbCtD
Quinidine—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0315	0.0447	CbGbCtD
Quinidine—SLCO1B1—Methotrexate—systemic scleroderma	0.0299	0.0424	CbGbCtD
Quinidine—SLC22A8—Methotrexate—systemic scleroderma	0.0276	0.0391	CbGbCtD
Quinidine—ABCB1—Captopril—systemic scleroderma	0.0271	0.0385	CbGbCtD
Quinidine—ABCC2—Methotrexate—systemic scleroderma	0.0263	0.0373	CbGbCtD
Quinidine—CYP2D6—Captopril—systemic scleroderma	0.0256	0.0363	CbGbCtD
Quinidine—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0214	0.0303	CbGbCtD
Quinidine—ABCB1—Prednisone—systemic scleroderma	0.0171	0.0242	CbGbCtD
Quinidine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0128	0.0181	CbGbCtD
Quinidine—CYP3A4—Prednisone—systemic scleroderma	0.0102	0.0145	CbGbCtD
Quinidine—ABCB1—Methotrexate—systemic scleroderma	0.00856	0.0121	CbGbCtD
Quinidine—CYP2C9—cardial valve—systemic scleroderma	0.00579	0.3	CbGeAlD
Quinidine—KCNK1—tendon—systemic scleroderma	0.000799	0.0415	CbGeAlD
Quinidine—ABCB11—digestive system—systemic scleroderma	0.00074	0.0384	CbGeAlD
Quinidine—KCNK1—lung—systemic scleroderma	0.000701	0.0364	CbGeAlD
Quinidine—SLC22A2—digestive system—systemic scleroderma	0.000594	0.0308	CbGeAlD
Quinidine—SCN1A—lung—systemic scleroderma	0.000521	0.027	CbGeAlD
Quinidine—SCN5A—digestive system—systemic scleroderma	0.000501	0.026	CbGeAlD
Quinidine—SLCO1B1—digestive system—systemic scleroderma	0.000496	0.0257	CbGeAlD
Quinidine—SCN3A—tendon—systemic scleroderma	0.000479	0.0248	CbGeAlD
Quinidine—SLC22A4—digestive system—systemic scleroderma	0.00044	0.0229	CbGeAlD
Quinidine—SCN3A—lung—systemic scleroderma	0.00042	0.0218	CbGeAlD
Quinidine—SLC22A4—tendon—systemic scleroderma	0.000419	0.0217	CbGeAlD
Quinidine—SLCO1A2—digestive system—systemic scleroderma	0.000404	0.021	CbGeAlD
Quinidine—ORM1—lung—systemic scleroderma	0.000382	0.0198	CbGeAlD
Quinidine—ABCC2—digestive system—systemic scleroderma	0.000376	0.0195	CbGeAlD
Quinidine—SLC22A4—lung—systemic scleroderma	0.000368	0.0191	CbGeAlD
Quinidine—ABCB1—blood vessel—systemic scleroderma	0.000365	0.019	CbGeAlD
Quinidine—SLC22A5—skin of body—systemic scleroderma	0.000364	0.0189	CbGeAlD
Quinidine—ABCC2—tendon—systemic scleroderma	0.000358	0.0186	CbGeAlD
Quinidine—SLCO1A2—lung—systemic scleroderma	0.000337	0.0175	CbGeAlD
Quinidine—CYP1A1—skin of body—systemic scleroderma	0.000326	0.0169	CbGeAlD
Quinidine—CYP2B6—skin of body—systemic scleroderma	0.000316	0.0164	CbGeAlD
Quinidine—Palpitations—Lisinopril—systemic scleroderma	0.000304	0.0011	CcSEcCtD
Quinidine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000303	0.0011	CcSEcCtD
Quinidine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000303	0.0011	CcSEcCtD
Quinidine—Loss of consciousness—Lisinopril—systemic scleroderma	0.000302	0.0011	CcSEcCtD
Quinidine—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000301	0.00109	CcSEcCtD
Quinidine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000301	0.00109	CcSEcCtD
Quinidine—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.0003	0.00109	CcSEcCtD
Quinidine—Muscular weakness—Prednisone—systemic scleroderma	0.000299	0.00108	CcSEcCtD
Quinidine—Visual disturbance—Methotrexate—systemic scleroderma	0.000299	0.00108	CcSEcCtD
Quinidine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000299	0.00108	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000298	0.00108	CcSEcCtD
Quinidine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000297	0.00108	CcSEcCtD
Quinidine—Myalgia—Lisinopril—systemic scleroderma	0.000293	0.00106	CcSEcCtD
Quinidine—Chest pain—Lisinopril—systemic scleroderma	0.000293	0.00106	CcSEcCtD
Quinidine—SLC22A5—digestive system—systemic scleroderma	0.000291	0.0151	CbGeAlD
Quinidine—Dyspnoea—Leflunomide—systemic scleroderma	0.000291	0.00106	CcSEcCtD
Quinidine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000291	0.00106	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000291	0.00105	CcSEcCtD
Quinidine—Vomiting—Mometasone—systemic scleroderma	0.000287	0.00104	CcSEcCtD
Quinidine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000285	0.00103	CcSEcCtD
Quinidine—Rash—Mometasone—systemic scleroderma	0.000284	0.00103	CcSEcCtD
Quinidine—Asthenia—Captopril—systemic scleroderma	0.000284	0.00103	CcSEcCtD
Quinidine—Dermatitis—Mometasone—systemic scleroderma	0.000284	0.00103	CcSEcCtD
Quinidine—Decreased appetite—Leflunomide—systemic scleroderma	0.000284	0.00103	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000284	0.00103	CcSEcCtD
Quinidine—Confusional state—Lisinopril—systemic scleroderma	0.000283	0.00103	CcSEcCtD
Quinidine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000283	0.00103	CcSEcCtD
Quinidine—Headache—Mometasone—systemic scleroderma	0.000283	0.00102	CcSEcCtD
Quinidine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000282	0.00102	CcSEcCtD
Quinidine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000282	0.00102	CcSEcCtD
Quinidine—Oedema—Lisinopril—systemic scleroderma	0.000281	0.00102	CcSEcCtD
Quinidine—Pruritus—Captopril—systemic scleroderma	0.00028	0.00102	CcSEcCtD
Quinidine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000278	0.00101	CcSEcCtD
Quinidine—SLC22A5—tendon—systemic scleroderma	0.000277	0.0144	CbGeAlD
Quinidine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000277	0.001	CcSEcCtD
Quinidine—Shock—Lisinopril—systemic scleroderma	0.000276	0.001	CcSEcCtD
Quinidine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000275	0.000998	CcSEcCtD
Quinidine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000275	0.000996	CcSEcCtD
Quinidine—Neutropenia—Prednisone—systemic scleroderma	0.000274	0.000994	CcSEcCtD
Quinidine—Tachycardia—Lisinopril—systemic scleroderma	0.000274	0.000993	CcSEcCtD
Quinidine—Abdominal pain—Azathioprine—systemic scleroderma	0.000273	0.000991	CcSEcCtD
Quinidine—Body temperature increased—Azathioprine—systemic scleroderma	0.000273	0.000991	CcSEcCtD
Quinidine—Skin disorder—Lisinopril—systemic scleroderma	0.000273	0.000988	CcSEcCtD
Quinidine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000271	0.000983	CcSEcCtD
Quinidine—Diarrhoea—Captopril—systemic scleroderma	0.000271	0.000983	CcSEcCtD
Quinidine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000271	0.000982	CcSEcCtD
Quinidine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000271	0.000981	CcSEcCtD
Quinidine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00027	0.000979	CcSEcCtD
Quinidine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00027	0.000978	CcSEcCtD
Quinidine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000269	0.000976	CcSEcCtD
Quinidine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000269	0.000975	CcSEcCtD
Quinidine—Nausea—Mometasone—systemic scleroderma	0.000268	0.000971	CcSEcCtD
Quinidine—Anorexia—Lisinopril—systemic scleroderma	0.000267	0.00097	CcSEcCtD
Quinidine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000267	0.000968	CcSEcCtD
Quinidine—Ataxia—Methotrexate—systemic scleroderma	0.000266	0.000966	CcSEcCtD
Quinidine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000266	0.000965	CcSEcCtD
Quinidine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000265	0.00096	CcSEcCtD
Quinidine—CYP1A2—digestive system—systemic scleroderma	0.000264	0.0137	CbGeAlD
Quinidine—Hypotension—Lisinopril—systemic scleroderma	0.000262	0.000951	CcSEcCtD
Quinidine—Dizziness—Captopril—systemic scleroderma	0.000262	0.00095	CcSEcCtD
Quinidine—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000262	0.000948	CcSEcCtD
Quinidine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000261	0.000946	CcSEcCtD
Quinidine—CYP1A1—digestive system—systemic scleroderma	0.00026	0.0135	CbGeAlD
Quinidine—Urticaria—Leflunomide—systemic scleroderma	0.000259	0.000941	CcSEcCtD
Quinidine—Abdominal pain—Leflunomide—systemic scleroderma	0.000258	0.000936	CcSEcCtD
Quinidine—Body temperature increased—Leflunomide—systemic scleroderma	0.000258	0.000936	CcSEcCtD
Quinidine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000257	0.000931	CcSEcCtD
Quinidine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000256	0.00093	CcSEcCtD
Quinidine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000256	0.00093	CcSEcCtD
Quinidine—Breast disorder—Methotrexate—systemic scleroderma	0.000256	0.000928	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000256	0.000927	CcSEcCtD
Quinidine—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000255	0.000925	CcSEcCtD
Quinidine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000255	0.000924	CcSEcCtD
Quinidine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000255	0.000924	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000255	0.000923	CcSEcCtD
Quinidine—CYP2B6—digestive system—systemic scleroderma	0.000253	0.0131	CbGeAlD
Quinidine—Vomiting—Captopril—systemic scleroderma	0.000252	0.000913	CcSEcCtD
Quinidine—CYP2C9—digestive system—systemic scleroderma	0.000251	0.013	CbGeAlD
Quinidine—Dyspnoea—Lisinopril—systemic scleroderma	0.00025	0.000907	CcSEcCtD
Quinidine—Rash—Captopril—systemic scleroderma	0.00025	0.000906	CcSEcCtD
Quinidine—Dermatitis—Captopril—systemic scleroderma	0.00025	0.000905	CcSEcCtD
Quinidine—Headache—Captopril—systemic scleroderma	0.000248	0.0009	CcSEcCtD
Quinidine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000248	0.000899	CcSEcCtD
Quinidine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000246	0.000893	CcSEcCtD
Quinidine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000246	0.000893	CcSEcCtD
Quinidine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000246	0.000891	CcSEcCtD
Quinidine—Asthma—Methotrexate—systemic scleroderma	0.000245	0.000888	CcSEcCtD
Quinidine—Decreased appetite—Lisinopril—systemic scleroderma	0.000244	0.000884	CcSEcCtD
Quinidine—SLC22A5—lung—systemic scleroderma	0.000243	0.0126	CbGeAlD
Quinidine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000242	0.000878	CcSEcCtD
Quinidine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000877	CcSEcCtD
Quinidine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000241	0.000874	CcSEcCtD
Quinidine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000241	0.000873	CcSEcCtD
Quinidine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000241	0.000872	CcSEcCtD
Quinidine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00024	0.00087	CcSEcCtD
Quinidine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000239	0.000866	CcSEcCtD
Quinidine—Bradycardia—Prednisone—systemic scleroderma	0.000239	0.000866	CcSEcCtD
Quinidine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000238	0.000862	CcSEcCtD
Quinidine—CYP2E1—digestive system—systemic scleroderma	0.000237	0.0123	CbGeAlD
Quinidine—Diarrhoea—Azathioprine—systemic scleroderma	0.000237	0.000858	CcSEcCtD
Quinidine—Haemoglobin—Prednisone—systemic scleroderma	0.000236	0.000855	CcSEcCtD
Quinidine—Nausea—Captopril—systemic scleroderma	0.000235	0.000853	CcSEcCtD
Quinidine—Haemorrhage—Prednisone—systemic scleroderma	0.000235	0.00085	CcSEcCtD
Quinidine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000234	0.00085	CcSEcCtD
Quinidine—Asthenia—Leflunomide—systemic scleroderma	0.000234	0.000849	CcSEcCtD
Quinidine—Pancytopenia—Methotrexate—systemic scleroderma	0.000233	0.000843	CcSEcCtD
Quinidine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000231	0.000838	CcSEcCtD
Quinidine—Pruritus—Leflunomide—systemic scleroderma	0.000231	0.000838	CcSEcCtD
Quinidine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00023	0.000833	CcSEcCtD
Quinidine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000229	0.000832	CcSEcCtD
Quinidine—Neutropenia—Methotrexate—systemic scleroderma	0.000229	0.00083	CcSEcCtD
Quinidine—Dizziness—Azathioprine—systemic scleroderma	0.000229	0.000829	CcSEcCtD
Quinidine—CYP2E1—tendon—systemic scleroderma	0.000226	0.0117	CbGeAlD
Quinidine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000224	0.000812	CcSEcCtD
Quinidine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000224	0.00081	CcSEcCtD
Quinidine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000224	0.00081	CcSEcCtD
Quinidine—Diarrhoea—Leflunomide—systemic scleroderma	0.000223	0.00081	CcSEcCtD
Quinidine—Urticaria—Lisinopril—systemic scleroderma	0.000223	0.000808	CcSEcCtD
Quinidine—Abdominal pain—Lisinopril—systemic scleroderma	0.000222	0.000804	CcSEcCtD
Quinidine—Body temperature increased—Lisinopril—systemic scleroderma	0.000222	0.000804	CcSEcCtD
Quinidine—CYP1A2—lung—systemic scleroderma	0.00022	0.0114	CbGeAlD
Quinidine—Pruritus—Mycophenolic acid—systemic scleroderma	0.00022	0.000799	CcSEcCtD
Quinidine—Vomiting—Azathioprine—systemic scleroderma	0.00022	0.000797	CcSEcCtD
Quinidine—Eye disorder—Prednisone—systemic scleroderma	0.000219	0.000795	CcSEcCtD
Quinidine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000219	0.000795	CcSEcCtD
Quinidine—Rash—Azathioprine—systemic scleroderma	0.000218	0.00079	CcSEcCtD
Quinidine—Dermatitis—Azathioprine—systemic scleroderma	0.000218	0.00079	CcSEcCtD
Quinidine—Flushing—Prednisone—systemic scleroderma	0.000218	0.000789	CcSEcCtD
Quinidine—CYP1A1—lung—systemic scleroderma	0.000217	0.0113	CbGeAlD
Quinidine—Headache—Azathioprine—systemic scleroderma	0.000217	0.000785	CcSEcCtD
Quinidine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000217	0.000785	CcSEcCtD
Quinidine—Dizziness—Leflunomide—systemic scleroderma	0.000216	0.000783	CcSEcCtD
Quinidine—Renal failure—Methotrexate—systemic scleroderma	0.000215	0.000778	CcSEcCtD
Quinidine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000214	0.000775	CcSEcCtD
Quinidine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000213	0.000773	CcSEcCtD
Quinidine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000212	0.00077	CcSEcCtD
Quinidine—Immune system disorder—Prednisone—systemic scleroderma	0.000212	0.000768	CcSEcCtD
Quinidine—CYP2B6—lung—systemic scleroderma	0.000211	0.011	CbGeAlD
Quinidine—Sweating—Methotrexate—systemic scleroderma	0.000209	0.000759	CcSEcCtD
Quinidine—Vomiting—Leflunomide—systemic scleroderma	0.000208	0.000753	CcSEcCtD
Quinidine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000207	0.00075	CcSEcCtD
Quinidine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000206	0.000747	CcSEcCtD
Quinidine—Rash—Leflunomide—systemic scleroderma	0.000206	0.000746	CcSEcCtD
Quinidine—Dermatitis—Leflunomide—systemic scleroderma	0.000206	0.000746	CcSEcCtD
Quinidine—Mental disorder—Prednisone—systemic scleroderma	0.000206	0.000745	CcSEcCtD
Quinidine—Nausea—Azathioprine—systemic scleroderma	0.000205	0.000745	CcSEcCtD
Quinidine—Headache—Leflunomide—systemic scleroderma	0.000205	0.000742	CcSEcCtD
Quinidine—Erythema—Prednisone—systemic scleroderma	0.000204	0.00074	CcSEcCtD
Quinidine—Malnutrition—Prednisone—systemic scleroderma	0.000204	0.00074	CcSEcCtD
Quinidine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000204	0.000739	CcSEcCtD
Quinidine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000203	0.000735	CcSEcCtD
Quinidine—Asthenia—Lisinopril—systemic scleroderma	0.000201	0.00073	CcSEcCtD
Quinidine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000201	0.000729	CcSEcCtD
Quinidine—Pruritus—Lisinopril—systemic scleroderma	0.000199	0.00072	CcSEcCtD
Quinidine—CYP2E1—lung—systemic scleroderma	0.000198	0.0103	CbGeAlD
Quinidine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000198	0.000718	CcSEcCtD
Quinidine—Haemoglobin—Methotrexate—systemic scleroderma	0.000197	0.000714	CcSEcCtD
Quinidine—Rash—Mycophenolic acid—systemic scleroderma	0.000196	0.000712	CcSEcCtD
Quinidine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000196	0.000711	CcSEcCtD
Quinidine—Haemorrhage—Methotrexate—systemic scleroderma	0.000196	0.000711	CcSEcCtD
Quinidine—Hepatitis—Methotrexate—systemic scleroderma	0.000196	0.000711	CcSEcCtD
Quinidine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000708	CcSEcCtD
Quinidine—Headache—Mycophenolic acid—systemic scleroderma	0.000195	0.000708	CcSEcCtD
Quinidine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000194	0.000705	CcSEcCtD
Quinidine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000194	0.000705	CcSEcCtD
Quinidine—Nausea—Leflunomide—systemic scleroderma	0.000194	0.000703	CcSEcCtD
Quinidine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000194	0.000702	CcSEcCtD
Quinidine—Vision blurred—Prednisone—systemic scleroderma	0.000192	0.000698	CcSEcCtD
Quinidine—Urethral disorder—Methotrexate—systemic scleroderma	0.000192	0.000697	CcSEcCtD
Quinidine—Diarrhoea—Lisinopril—systemic scleroderma	0.000192	0.000696	CcSEcCtD
Quinidine—CYP3A4—digestive system—systemic scleroderma	0.000191	0.00992	CbGeAlD
Quinidine—Visual impairment—Methotrexate—systemic scleroderma	0.000189	0.000685	CcSEcCtD
Quinidine—CYP2D6—digestive system—systemic scleroderma	0.000188	0.00976	CbGeAlD
Quinidine—Agitation—Prednisone—systemic scleroderma	0.000188	0.00068	CcSEcCtD
Quinidine—Angioedema—Prednisone—systemic scleroderma	0.000187	0.000676	CcSEcCtD
Quinidine—Dizziness—Lisinopril—systemic scleroderma	0.000186	0.000673	CcSEcCtD
Quinidine—Erythema multiforme—Methotrexate—systemic scleroderma	0.000185	0.000672	CcSEcCtD
Quinidine—Nausea—Mycophenolic acid—systemic scleroderma	0.000185	0.000671	CcSEcCtD
Quinidine—Vertigo—Prednisone—systemic scleroderma	0.000183	0.000665	CcSEcCtD
Quinidine—Eye disorder—Methotrexate—systemic scleroderma	0.000183	0.000664	CcSEcCtD
Quinidine—Syncope—Prednisone—systemic scleroderma	0.000183	0.000664	CcSEcCtD
Quinidine—Tinnitus—Methotrexate—systemic scleroderma	0.000183	0.000663	CcSEcCtD
Quinidine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000182	0.00066	CcSEcCtD
Quinidine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000181	0.000657	CcSEcCtD
Quinidine—Loss of consciousness—Prednisone—systemic scleroderma	0.000179	0.000651	CcSEcCtD
Quinidine—Vomiting—Lisinopril—systemic scleroderma	0.000178	0.000647	CcSEcCtD
Quinidine—Immune system disorder—Methotrexate—systemic scleroderma	0.000177	0.000642	CcSEcCtD
Quinidine—Rash—Lisinopril—systemic scleroderma	0.000177	0.000641	CcSEcCtD
Quinidine—Convulsion—Prednisone—systemic scleroderma	0.000177	0.000641	CcSEcCtD
Quinidine—Dermatitis—Lisinopril—systemic scleroderma	0.000177	0.000641	CcSEcCtD
Quinidine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000177	0.000641	CcSEcCtD
Quinidine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000176	0.00064	CcSEcCtD
Quinidine—Chills—Methotrexate—systemic scleroderma	0.000176	0.000638	CcSEcCtD
Quinidine—Headache—Lisinopril—systemic scleroderma	0.000176	0.000637	CcSEcCtD
Quinidine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000631	CcSEcCtD
Quinidine—Myalgia—Prednisone—systemic scleroderma	0.000174	0.00063	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000173	0.000626	CcSEcCtD
Quinidine—Mental disorder—Methotrexate—systemic scleroderma	0.000172	0.000623	CcSEcCtD
Quinidine—Malnutrition—Methotrexate—systemic scleroderma	0.000171	0.000619	CcSEcCtD
Quinidine—Erythema—Methotrexate—systemic scleroderma	0.000171	0.000619	CcSEcCtD
Quinidine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000168	0.00061	CcSEcCtD
Quinidine—Nausea—Lisinopril—systemic scleroderma	0.000167	0.000604	CcSEcCtD
Quinidine—Oedema—Prednisone—systemic scleroderma	0.000167	0.000604	CcSEcCtD
Quinidine—Shock—Prednisone—systemic scleroderma	0.000164	0.000594	CcSEcCtD
Quinidine—Nervous system disorder—Prednisone—systemic scleroderma	0.000163	0.000593	CcSEcCtD
Quinidine—Tachycardia—Prednisone—systemic scleroderma	0.000163	0.00059	CcSEcCtD
Quinidine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000163	0.000589	CcSEcCtD
Quinidine—Skin disorder—Prednisone—systemic scleroderma	0.000162	0.000587	CcSEcCtD
Quinidine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000161	0.000584	CcSEcCtD
Quinidine—Vision blurred—Methotrexate—systemic scleroderma	0.000161	0.000583	CcSEcCtD
Quinidine—Anorexia—Prednisone—systemic scleroderma	0.000159	0.000576	CcSEcCtD
Quinidine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000156	0.000567	CcSEcCtD
Quinidine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000562	CcSEcCtD
Quinidine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000561	CcSEcCtD
Quinidine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000558	CcSEcCtD
Quinidine—Vertigo—Methotrexate—systemic scleroderma	0.000153	0.000556	CcSEcCtD
Quinidine—Leukopenia—Methotrexate—systemic scleroderma	0.000153	0.000554	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000152	0.00055	CcSEcCtD
Quinidine—Convulsion—Methotrexate—systemic scleroderma	0.000148	0.000536	CcSEcCtD
Quinidine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000146	0.000529	CcSEcCtD
Quinidine—Chest pain—Methotrexate—systemic scleroderma	0.000145	0.000527	CcSEcCtD
Quinidine—Myalgia—Methotrexate—systemic scleroderma	0.000145	0.000527	CcSEcCtD
Quinidine—Decreased appetite—Prednisone—systemic scleroderma	0.000145	0.000525	CcSEcCtD
Quinidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000144	0.000523	CcSEcCtD
Quinidine—Confusional state—Methotrexate—systemic scleroderma	0.00014	0.000509	CcSEcCtD
Quinidine—Feeling abnormal—Prednisone—systemic scleroderma	0.000137	0.000498	CcSEcCtD
Quinidine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000137	0.000495	CcSEcCtD
Quinidine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000136	0.000494	CcSEcCtD
Quinidine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000136	0.000494	CcSEcCtD
Quinidine—Skin disorder—Methotrexate—systemic scleroderma	0.000135	0.00049	CcSEcCtD
Quinidine—ABCB1—digestive system—systemic scleroderma	0.000135	0.00702	CbGeAlD
Quinidine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000135	0.000488	CcSEcCtD
Quinidine—Anorexia—Methotrexate—systemic scleroderma	0.000133	0.000481	CcSEcCtD
Quinidine—Urticaria—Prednisone—systemic scleroderma	0.000132	0.00048	CcSEcCtD
Quinidine—Abdominal pain—Prednisone—systemic scleroderma	0.000132	0.000478	CcSEcCtD
Quinidine—Body temperature increased—Prednisone—systemic scleroderma	0.000132	0.000478	CcSEcCtD
Quinidine—Hypotension—Methotrexate—systemic scleroderma	0.00013	0.000472	CcSEcCtD
Quinidine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000127	0.00046	CcSEcCtD
Quinidine—Dyspnoea—Methotrexate—systemic scleroderma	0.000124	0.00045	CcSEcCtD
Quinidine—Hypersensitivity—Prednisone—systemic scleroderma	0.000123	0.000445	CcSEcCtD
Quinidine—Decreased appetite—Methotrexate—systemic scleroderma	0.000121	0.000439	CcSEcCtD
Quinidine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00012	0.000436	CcSEcCtD
Quinidine—Asthenia—Prednisone—systemic scleroderma	0.00012	0.000433	CcSEcCtD
Quinidine—Pruritus—Prednisone—systemic scleroderma	0.000118	0.000427	CcSEcCtD
Quinidine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000115	0.000416	CcSEcCtD
Quinidine—Diarrhoea—Prednisone—systemic scleroderma	0.000114	0.000413	CcSEcCtD
Quinidine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000114	0.000413	CcSEcCtD
Quinidine—ABCB1—lung—systemic scleroderma	0.000113	0.00586	CbGeAlD
Quinidine—Urticaria—Methotrexate—systemic scleroderma	0.000111	0.000401	CcSEcCtD
Quinidine—Dizziness—Prednisone—systemic scleroderma	0.00011	0.0004	CcSEcCtD
Quinidine—Body temperature increased—Methotrexate—systemic scleroderma	0.00011	0.000399	CcSEcCtD
Quinidine—Abdominal pain—Methotrexate—systemic scleroderma	0.00011	0.000399	CcSEcCtD
Quinidine—Vomiting—Prednisone—systemic scleroderma	0.000106	0.000384	CcSEcCtD
Quinidine—Rash—Prednisone—systemic scleroderma	0.000105	0.000381	CcSEcCtD
Quinidine—Dermatitis—Prednisone—systemic scleroderma	0.000105	0.000381	CcSEcCtD
Quinidine—Headache—Prednisone—systemic scleroderma	0.000104	0.000379	CcSEcCtD
Quinidine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000103	0.000372	CcSEcCtD
Quinidine—Asthenia—Methotrexate—systemic scleroderma	9.99e-05	0.000362	CcSEcCtD
Quinidine—Nausea—Prednisone—systemic scleroderma	9.9e-05	0.000359	CcSEcCtD
Quinidine—Pruritus—Methotrexate—systemic scleroderma	9.85e-05	0.000357	CcSEcCtD
Quinidine—Diarrhoea—Methotrexate—systemic scleroderma	9.53e-05	0.000345	CcSEcCtD
Quinidine—Dizziness—Methotrexate—systemic scleroderma	9.21e-05	0.000334	CcSEcCtD
Quinidine—Vomiting—Methotrexate—systemic scleroderma	8.86e-05	0.000321	CcSEcCtD
Quinidine—Rash—Methotrexate—systemic scleroderma	8.78e-05	0.000318	CcSEcCtD
Quinidine—Dermatitis—Methotrexate—systemic scleroderma	8.77e-05	0.000318	CcSEcCtD
Quinidine—Headache—Methotrexate—systemic scleroderma	8.73e-05	0.000316	CcSEcCtD
Quinidine—Nausea—Methotrexate—systemic scleroderma	8.27e-05	0.0003	CcSEcCtD
